Condition: Acute Kidney Injury · ESRD · Sponsor: Fresenius Medical Care North America
This is an Open-label, Prospective, Multicenter Study to Assess the SAfety of Regional Citrate Anticoagulation Delivered by the multiFiltratePRO system in Adult Patients Requiring Continuous Renal Replacement Therapy (SARCA Study).
This description comes directly from the study's public registry record.
Anja Derlet-Savoia, PhD · +49 173 965 9356 · anja.derlet@freseniusmedicalcare.com
Manuela Stauss-Grabo, PhD · +49 1525 469 1929 · manuela.stauss-grabo1@freseniusmedicalcare.com
Always discuss trial participation with your own doctor first.
| John L. McClellan Memorial Veterans' Hospital | Little Rock, Arkansas, United States | Completed |
| University of Arkansas for Medical Sciences (UAMS) | Little Rock, Arkansas, United States | Recruiting |
| Advent Health Orlando | Orlando, Florida, United States | Not Yet Recruiting |
| UMass Memorial Medical Center | Worcester, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Completed |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Completed |
| University of Mississippi Medical Center | Jackson, Mississippi, United States | Recruiting |
| Washington University - Hospital | St Louis, Missouri, United States | Completed |
| Intermountain Health | Murray, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05339139